Prevalence of GAD(65) and IA-2 autoantibodies in IDDM patients with nephropathy.

被引：0

作者：

Zerbini, G ^{[1
]}

Bazzigaluppi, E ^{[1
]}

Mangili, R ^{[1
]}

Bosi, E ^{[1
]}

Bonifacio, E ^{[1
]}

机构：

[1] IST SCI SAN RAFFAELE,MILAN,ITALY

来源：

DIABETOLOGIA | 1997年 / 40卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：2090 / 2090

页数：1

共 50 条

[31] Associations of GAD65- and IA-2-autoantibodies with genetic risk markers in new-onset IDDM patients and their siblings [J].

Vandewalle, CL ;

Falorni, A ;

Lernmark, A ;

Goubert, P ;

Dorchy, H ;

Coucke, W ;

Semakula, C ;

VanderAuwera, B ;

Kaufman, L ;

Schuit, FC ;

Pipeleers, DG ;

Gorus, FK ;

Balasse, E ;

Becq, H ;

Bodson, A ;

Claeys, L ;

Coeckelberghs, M ;

Coolens, JL ;

Couturier, E ;

Craen, R ;

Daubresse, JC ;

Decraene, P ;

DeLeeuw, I ;

Delvigne, C ;

DeSchepper, J ;

DuCaju, M ;

Fery, F ;

Gaham, N ;

Gerard, J ;

Gillet, C ;

Guiot, J ;

Herbaut, C ;

Keymeulen, B ;

Krzentowski, G ;

Lamberigts, G ;

Letiexhe, M ;

Logghe, K ;

Monballyu, J ;

Nicolaij, D ;

Nobels, F ;

Pelckmans, MC ;

Purnode, A ;

Roggemans, MP ;

Rottiers, R ;

Scheen, A ;

Schutyser, J ;

Terriere, L ;

Teuwen, J ;

Thenaers, G ;

VanAcker, K .

DIABETES CARE, 1997, 20 (10) :1547-1552

[32] Only multiple autoantibodies to islet cells (ICA), insulin, GAD65, IA-2 and IA-2β predict immune-mediated (type 1) diabetes in relatives [J].

Maclaren, N ;

Lan, M ;

Coutant, R ;

Schatz, D ;

Silverstein, J ;

Muir, A ;

Clare-Salzer, M ;

She, JX ;

Malone, J ;

Crockett, S ;

Schwartz, S ;

Quattrin, T ;

DeSilva, M ;

Vander Vegt, P ;

Notkins, A ;

Krischer, J .

JOURNAL OF AUTOIMMUNITY, 1999, 12 (04) :279-287

[33] GAD65 and IA-2 autoantibodies identify latent autoimmune diabetes of adulthood in phenotypic type 2 diabetes in Canadians [J].

Behme, MT ;

Mahon, JL ;

Dupre, J .

DIABETES, 2001, 50 :A258-A258

[34] Frequency of islet cell autoantibodies (IA-2 and GAD) in young Brazilian type 1 diabetes patients [J].

Pardini, VC ;

Mourao, DM ;

Nascimento, PD ;

Vívolo, MA ;

Ferreira, SRG ;

Pardini, H .

BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 1999, 32 (10) :1195-1198

[35] Comments on the relation among GAD–65, IA-2 antibodies and body adiposity [J].

Diabetologia, 2000, 43 (1) :134-134

[36] Autoantibodies against GAD65 and IA-2 in recently diagnosed Type 1 diabetic children from Western India [J].

Marita, AR ;

Rane, S ;

Mokal, RA ;

Nair, SR ;

Irani, A .

DIABETIC MEDICINE, 2004, 21 (08) :956-957

[37] Combined screening for autoantibodies to IA-2 and antibodies to glutamic acid decarboxylase in first degree relatives of patients with IDDM [J].

Seissler, J ;

Morgenthaler, NG ;

Achenbach, P ;

Lampeter, EF ;

Glawe, D ;

Payton, M ;

Christie, M ;

Scherbaum, WA .

DIABETOLOGIA, 1996, 39 (11) :1351-1356

[38] Tyrosine phosphatase-like protein (IA-2) and glutamic acid decarboxylase (GAD65) autoantibodies: A study of Chinese patients with diabetes mellitus [J].

Ng, WY ;

Lee, YS ;

Todd, AL ;

Liu, KF ;

Loke, KY ;

Thai, AC .

AUTOIMMUNITY, 2002, 35 (02) :119-124

[39] Four HLA-DQ heterodimers are potent risk factors for IDDM in the absence of GAD65, IA-2 and islet cell antibodies [J].

Pietropaolo, M ;

Rudert, WA ;

Laporte, RE ;

Becker, DJ ;

Trucco, M .

DIABETES, 1998, 47 :A209-A209

[40] Comments on the relation among GAD-65, IA-2 antibodies and body adiposity [J].

Porte, D ;

Seeley, RJ ;

Woods, SC ;

Baskin, DG ;

Figlewicz, DP ;

Schwartz, MW .

DIABETOLOGIA, 2000, 43 (01) :134-134

← 1 2 3 4 5 →